Mobile Education App for Childhood Epilepsy
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a mobile app designed to help families manage childhood epilepsy. The app, called the Mobile Epilepsy Education Package (MEEP or Mobile Epilepsy Education Application), provides educational content and tools for tracking symptoms and medical appointments. Researchers aim to determine if this app can reduce anxiety and improve outcomes for families managing epilepsy. Eligible families have children aged 1-17 who were diagnosed with epilepsy at least two months ago and regularly use a smartphone. Participants will either use this app or receive standard epilepsy education from the hospital. As an unphased trial, this study allows families to contribute to innovative research that could enhance epilepsy management and support.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that this mobile education app is safe for children with epilepsy?
Research has shown that the Mobile Epilepsy Education Package (MEEP) helps parents learn more about epilepsy and reduces anxiety. In Turkey, the app has been used successfully, yielding positive results without any reported safety concerns. As an educational tool, MEEP does not involve medication or medical procedures, thus minimizing the risk of side effects.
The primary goal of the MEEP app is to provide information and support to families managing childhood epilepsy. It educates caregivers, boosting their confidence in handling their child's condition. Due to its educational focus, it is generally well-received and avoids the side effects associated with medications or invasive treatments.12345Why are researchers excited about this trial?
Researchers are excited about the Mobile Epilepsy Education Package (MEEP) for childhood epilepsy because it introduces a new way of supporting children and their families through an accessible mobile app. Unlike traditional education methods that rely on in-person consultations, MEEP offers a convenient digital platform that includes both educational content and a parental monitoring section. This approach not only empowers parents with knowledge but also allows for real-time monitoring and management of their child’s condition, potentially improving outcomes and reducing the stress associated with managing epilepsy.
What evidence suggests that the Mobile Epilepsy Education Package is effective for childhood epilepsy?
Research has shown that the Mobile Epilepsy Education Package (MEEP), which participants in this trial may receive, helps parents learn more about epilepsy and feel less anxious. Studies have found that parents using MEEP gain a better understanding of epilepsy-related issues. This app also reduces the worry parents often have about their child's condition. In one study, researchers adapted MEEP for use in Canada and observed similar positive results. Overall, MEEP provides an easy and straightforward way for parents to access important information and support.12456
Who Is on the Research Team?
Kenneth Alexis Myers, MD PhD FRCPC
Principal Investigator
RI-MUHC, Montreal Children's Hospital, McGill University
Dilek Sayik, RN, PhD
Principal Investigator
Ingram School of Nursing, McGill University
Ayfer Acikgoz, RN, PhD
Principal Investigator
Faculty of Health Sciences, Eskisehir Osmangazi University
Argerie Tsimicalis, RN, PhD
Principal Investigator
Shriners Hospitals for Children, Ingram School of Nursing, McGill University
Are You a Good Fit for This Trial?
This trial is for caregivers of children aged 1-17 with epilepsy treated at the Montreal Children's Hospital. It aims to help families manage anxiety and improve knowledge about epilepsy through a mobile app. Participants must be able to use the app in English or French.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants use the Mobile Epilepsy Education Package (MEEP) for 4 weeks, which includes educational content and a Parental Monitoring Section
Follow-up
Participants are monitored for changes in epilepsy knowledge and anxiety levels after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Mobile Epilepsy Education Package
Mobile Epilepsy Education Package is already approved in Canada for the following indications:
- Epilepsy education and management
Find a Clinic Near You
Who Is Running the Clinical Trial?
McGill University Health Centre/Research Institute of the McGill University Health Centre
Lead Sponsor
The Scientific and Technological Research Council of Turkey
Collaborator